Westchester Capital Management (New York)’s Pfizer PFE Stock Holding History

Westchester Capital Management (New York)’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-378,913	Closed	-$10.7M	–	99
2016 Q1	$10.7M	Sell	378,913 -2,003	-0.5%	-$57.2K	0.21%	62
2015 Q4	$11.7M	Buy	+380,916	New	+$12M	0.21%	68
2015 Q1	–	Sell	-327,794	Closed	-$9.69M	–	93
2014 Q4	$9.69M	Buy	327,794 +160,840	+96%	+$4.61M	0.16%	76
2014 Q3	$4.68M	Sell	166,954 -1,509,011	-90%	-$42.4M	0.06%	114
2014 Q2	$47.2M	Sell	1,675,965 -375,646	-18%	-$10.7M	0.6%	65
2014 Q1	$62.5M	Sell	2,051,611 -87,904	-4%	-$2.62M	0.82%	50
2013 Q4	$62.2M	Sell	2,139,515 -297,649	-12%	-$8.66M	0.92%	46
2013 Q3	$66.4M	Sell	2,437,164 -1,890,033	-44%	-$51.4M	1.2%	31
2013 Q2	$115M	Buy	+4,327,197	New	+$120M	2.14%	7

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Westchester Capital Management (New York)'s PFE Position: Q3 2016 in Review

Westchester Capital Management (New York) sold out of Pfizer (PFE) in Q3 2016, closing a stake of 6,713 shares — an estimated $224K sold.

Westchester Capital Management (New York) first reported a position in PFE in Q2 2013 and held it in 12 quarters. The position peaked at $117M in Q2 2014. 1,963 funds tracked by Wall St. Rank hold PFE as of Q3 2016.

Westchester Capital Management (New York) reported no remaining Pfizer position as of Q3 2016 after selling out during the quarter.
Westchester Capital Management (New York) sold 6,713 Pfizer shares in Q3 2016, an estimated $224K.
Westchester Capital Management (New York) first reported a position in Pfizer in Q2 2013 and held it in 12 quarters.
Westchester Capital Management (New York)'s Pfizer position peaked at $117M in Q2 2014.
1,963 funds tracked by Wall St. Rank held Pfizer as of Q3 2016.

Based on Westchester Capital Management (New York)'s 13F filing for Q3 2016, filed 14 Nov 2016.